Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

Nikkiso Co Ltd (6376)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,241.0 +15.0    +1.22%
02:00:29 - Closed. Currency in JPY ( Disclaimer )
  • Volume: 81,100
  • Bid/Ask: 1,240.0 / 1,243.0
  • Day's Range: 1,218.0 - 1,250.0
Type:  Equity
Market:  Japan
ISIN:  JP3668000007 
Nikkiso Co Ltd 1,241.0 +15.0 +1.22%

Nikkiso Co Ltd Company Profile

 
Get an in-depth profile of Nikkiso Co Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryMachinery, Tools, Heavy Vehicles, Trains & Ships
SectorIndustrials
Employees

8638

Equity Type

ORD

NIKKISO CO.,LTD. is a Japan-based company principally engaged in the manufacture and sale of industrial pumps, precision equipment and blood related products, among others. The Company operates in two business segments. Industrial Business segment conducts industrial business including the manufacture, sale and maintenance of industrial special pumps, as well as liquefied gas & industrial gas related equipment and devices. The Segment is also involved in precision equipment business, aerospace business and deep ultraviolet light emitting diode (LED) business. Medical Business segment’s products are dialysis-related products including hemodialysis and peritoneal dialysis, such as artificial dialysis machines, dialyzers, blood circuits, and powder-type dialysis agents. The Segment also manufactures, sells and maintains products and medicines related to CRRT (acute blood purification therapy), artificial pancreas devices that manage blood glucose, and energy devices for microwave surgery.

Contact Information

Address Yebisu Garden Place Tower 22nd Floor
20-3 Ebisu, 4-Chome Shibuya-ku Tokyo,150-6022
Japan
Phone 81 3 3443 3711
Fax 81 3 3473 4963

Top Executives

Name Age Since Title
Hisakazu Nakahigashi - 2017 Executive Officer, GM of Research & Engineering Institute and Director
Kenji Hida 67 2017 Audit & Supervisory Board Member
Hiroshi Nakamura 67 2009 Executive VP & Director
Eisuke Nagatomo 73 2012 Independent Outside Director
Toshihiko Kai 77 2003 Chairman, President & CEO
Yoshihiko Kinoshita 57 2016 Executive Officer, GM of Medical Division & Director
Masaru Yamamura 58 2017 Executive Officer, GM of Industrial Business Division & Director
Haruko Hirose 78 2018 Independent Outside Director
Mitsuaki Nakakubo 57 2015 Independent Outside Director
Junko Fukuda 78 2021 Independent Outside Director
Motohiro Takeuchi 65 2022 Standing Audit & Supervisory Board Member
Peter Wagner 58 2022 Director
Toshiaki Mitsumi 67 2019 Audit & Supervisory Board Member
Eiichiro Nakatani 64 2023 Outside Audit & Supervisory Board
Koichi Kato 52 2023 Director
Hisanao Amino 62 2023 Audit & Supervisory Board Member
Kenji Saito 59 2022 Executive Officer, GM of Aerospace Division & Director
Naoshi Ogasawara 58 2022 Outside Audit & Supervisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

6376 Comments

Write your thoughts about Nikkiso Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email